summary
Introduced
04/20/2021
04/20/2021
In Committee
04/20/2021
04/20/2021
Crossed Over
Passed
Dead
11/30/2022
11/30/2022
Introduced Session
2021-2022 Regular Session
Bill Summary
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
AI Summary
This bill amends the Controlled Substance, Drug, Device and Cosmetic Act to further provide for drug overdose response immunity. The key provisions are that individuals experiencing a drug overdose cannot be charged or prosecuted if: (1) a person who transported or reported the overdose and remained with the individual is entitled to immunity under the law; and (2) within 30 days of receiving written notice, the individual obtains screening and, if recommended, receives a referral for addiction treatment from an accredited provider. The bill also requires law enforcement or the court to provide written notice to the individual of the treatment requirements to qualify for immunity. The bill takes effect 60 days after enactment.
Committee Categories
Justice
Sponsors (5)
Christopher Quinn (R)*,
Scott Conklin (D),
Dave Delloso (D),
Maureen Madden (D),
Dave Zimmerman (R),
Last Action
Referred to JUDICIARY (on 04/20/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2021&sind=0&body=H&type=B&bn=1238 | 04/20/2021 |
| Bill | https://www.legis.state.pa.us/cfdocs/legis/PN/Public/btCheck.cfm?txtType=PDF&sessYr=2021&sessInd=0&billBody=H&billTyp=B&billNbr=1238&pn=1302 | 04/21/2021 |
Loading...